CDKN2A and cancer: The interaction with mitochondrial p32 has been shown to be required for the induction of mitochondrial-dependent cell death in cancer cells by the pro-death Bcl2 family protein Hrk [9] and the tumour suppressor human p14 ARF [8], suggesting that p32 potentially acts as a tumour suppressor.